Document Classification

Section Type: RESULTS

Text: Among all HOPE patients, there were no significant differences in the primary analysis : for cancer incidence, there were 552 patients (11. 6 %) in the vitamin E group vs 586 (12. 3 %) in the placebo group (relative risk [RR], 0. 94 ; 95 % confidence interval [CI], 0. 84-1. 06 ; P =. 30) ; for cancer deaths, 156 (3. 3 %) vs 178 (3. 7 %), respectively (RR, 0. 88 ; 95 % CI, 0. 71-1. 09 ; P =. 24) ; and for major cardiovascular events, 1022 (21. 5 %) vs 985 (20. 6 %), respectively (RR, 1. 04 ; 95 % CI, 0. 96-1. 14 ; P =. 34).